Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
Clinical trial NCT06049680 · RECRUITING
Trial details
- NCT number
- NCT06049680
- Sponsor
- Fresenius Kabi
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-28
- Primary completion
- 2026-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.